Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000
Open Access
- 1 April 2003
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 9 (4), 432-437
- https://doi.org/10.3201/eid0904.020268
Abstract
During the 1990s, as antimicrobial resistance increased among pneumococci, many organizations promoted appropriate antimicrobial use to combat resistance. We analyzed data from the National Ambulatory Medical Care Survey, an annual sample survey of visits to office-based physicians, and the National Hospital Ambulatory Medical Care Survey, an annual sample survey of visits to hospital emergency and outpatient departments, to describe trends in antimicrobial prescribing from 1992 to 2000 in the United States. Approximately 1,100–1,900 physicians reported data from 21,000–37,000 visits; 200–300 outpatient departments reported data for 28,000–35,000 visits; ~400 emergency departments reported data for 21,000–36,000 visits each year. In that period, the population- and visit-based antimicrobial prescribing rates in ambulatory care settings decreased by 23% and 25%, respectively, driven largely by a decrease in prescribing by office-based physicians. Antimicrobial prescribing rates changed as follows: amoxicillin and ampicillin, –43%; cephalosporins, –28%; erythromycin, –76%; azithromycin and clarithromycin, +388%; quinolones, +78%; and amoxicillin/clavulanate, +72%. This increasing use of azithromycin, clarithromycin, and quinolones warrants concern as macrolide- and fluoroquinolone-resistant pneumococci are increasing.Keywords
This publication has 30 references indexed in Scilit:
- Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000Journal of Antimicrobial Chemotherapy, 2001
- The Emergence ofStreptococcus pneumoniaeResistant to Macrolide Antimicrobial Agents: A 6‐Year Population‐Based AssessmentThe Journal of Infectious Diseases, 2000
- Practice Guidelines for the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2000
- Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patientsPublished by American Medical Association (AMA) ,1997
- Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physiciansPublished by American Medical Association (AMA) ,1997
- Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working GroupPublished by American Medical Association (AMA) ,1996
- Trends in antimicrobial drug prescribing among office-based physicians in the United StatesPublished by American Medical Association (AMA) ,1995
- The Spread of Multiply Resistant Streptococcus pneumoniae at a Day Care Center in OhioThe Journal of Infectious Diseases, 1992
- The Crisis in Antibiotic ResistanceScience, 1992
- Antimicrobial Resistance in Hospital Organisms and Its Relation to Antibiotic UseClinical Infectious Diseases, 1983